{
    "2019-10-01": [
        [
            {
                "time": "2018-01-02",
                "original_text": "As Buyout Fever Grows, Alexion, Amarion and BioMarin Are Potential Targets",
                "features": {
                    "keywords": [
                        "buyout",
                        "Alexion",
                        "Amarion",
                        "BioMarin",
                        "potential targets"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Top Stock Reports for AbbVie, Starbucks & Phillips 66",
                "features": {
                    "keywords": [
                        "stock reports",
                        "AbbVie",
                        "Starbucks",
                        "Phillips 66"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "consumer goods",
                        "energy"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Falls 3%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Falls",
                        "3%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie- The Forest for the Trees",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "forest",
                        "trees"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}